Queen Elizabeth Hospital King’s Lynn Invented Device Awarded HSJ Patient Safety Innovation of the Year

The HSJ Patient Safety Awards Celebrated the Innovative Work of Frontline NHS Teams in a Year When the Challenge and Necessity of Keeping the Public Safe Had Never Been Greater

Summation

  • The Patient Safety Awards celebrate the teams at the frontline pushing the boundaries of patient safety and driving cultural change to minimise risk, enhance quality of care and ultimately save lives.
  • A ground-breaking regional anaesthesia device, invented by clinicians at The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust (QEH) and developed in conjunction with medical device company Medovate, has been awarded ‘Patient Safety Innovation of the Year' at this year's HSJ Patient Safety Awards.
  • The HSJ Patient Safety Awards celebrated the innovative work of frontline NHS teams in a year when the challenge and necessity of keeping the public safe had never been greater.

A ground-breaking regional anaesthesia device, invented by clinicians at The Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust (QEH) and developed in conjunction with medical device company Medovate, has been awarded Patient Safety Innovation of the Year’ at this year’s HSJ Patient Safety Awards.

The HSJ Patient Safety Awards celebrated the innovative work of frontline NHS teams in a year when the challenge and necessity of keeping the public safe had never been greater.

SAFIRA®: SAFer Injection for Regional Anaesthesia was recognised for its outstanding contribution to healthcare, fighting off competition from hundreds of applicants, with the judging panel highlighting its unique benefits for patient care:

The judges felt that this was an outstanding example of healthcare innovation which has clearly improved safety for both patients and staff. This innovation clearly demonstrates a reduction in known risk, with opportunity to enhance the patient experience, as well as contributing to the Greener NHS agenda. Overall, a great innovation for healthcare, with good evidence of scalability and transferability to other sectors.”

SAFIRA® is an intuitive, revolutionary technology which improves patient safety during regional anaesthesia (RA) by automatically limiting injection pressure thereby reducing the risk of nerve injury in patients. It also puts control of injection fully in the hands of the anaesthetist making it a single operator procedure.

SAFIRA® was taken through the entire development pathway, from regulatory approval to market launch, by Cambridge based Medovate and is now available globally.

The pioneering device was awarded the prestigious accolade based on its ambition, visionary spirit, and the demonstrable positive impact it has on patient and staff experiences within the healthcare sector.

Doctor Frankie Swords, Medical Director at QEH, said: “We are absolutely delighted that this exciting innovation, which has been developed by clinicians at QEH, was awarded Patient Safety Innovation of the Year. At QEH we are passionate about research and innovation which is critical to improving patient care, so I am delighted that we are leading the way on this. It is an incredible achievement, and we are extremely proud of everyone involved.”

The Patient Safety Awards celebrate the teams at the frontline pushing the boundaries of patient safety and driving cultural change to minimise risk, enhance quality of care and ultimately save lives.

Stuart Thomson, Managing Director at Medovate, added: “This is a great honour for everyone involved. There are approximately 20 million nerve blocks performed across Europe and the US per year and any nerve damage associated with these procedures can be potentially life changing for a patient.

“SAFIRA® provides an intuitive, cost effective technology to help reduce the risk of nerve damage from injection at high pressure, improving care for patients whilst also saving both time and cost. It’s a truly ground-breaking innovation which was designed in conjunction with the NHS and is already improving patient safety across the globe.”

The awards took place during the two-day Patient Safety Congress in Manchester and were deliberated upon by 125 judges over a two-stage process. In total there were 23 categories to judge, with 8 innovative projects shortlisted in each category.

The Patient Safety Innovation of the Year category was sponsored by the NHS Supply Chain and the results delivered by Director of Clinical and Product Assurance, NHS Supply Chain, Jo Gander, who was also on the judging panel.

Other judges included a diverse range of highly influential and respected figures within the healthcare community including Sue Smith OBE (Executive Chief Nurse and Deputy Chief Executive Officer, University Hospitals Morecambe Bay FT), Rachel Power (Chief Executive, The Patients Association), Dr Hester Wain (Head of Patient Safety Policy, NHS England and NHS Improvement).

The full list of finalists for the 2021 HSJ Patient Safety Awards can be found here: https://www.hsj.co.uk/patient-safety-awards/winners-of-hsj-patient-safety-awards-2021-revealed/7030921.article

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

- Advertisement -

spot_img

- Advertisement -

New Inflammatory Bowel Disease Center Opens at Northwell Health

The new Inflammatory Bowel Disease Center, located at 125 Community Drive in Manhasset, has 13 exam rooms, two procedural rooms and six infusion bays. Since it started operations, people have travelled from all over the country – and as far away as Alaska – to receive high-quality care.

Cold Spring Harbor Laboratory and Northwell Health Extend Strategic Affiliation

“The alliance between Cold Spring Harbor Laboratory (CSHL) and Northwell Health brings transformative bioscience research into the clinic,” says CSHL President & CEO Bruce Stillman. “As New York’s largest healthcare provider, Northwell Health serves a remarkably diverse patient population. This agreement will provide patient communities with greater access to cutting-edge biomedical technology, allowing for more precise diagnoses and treatments, and ultimately facilitating new breakthroughs in cancer care.”

Hackensack Meridian Neuroscience Institute at JFK University Medical Center Receives $2.2 Million Research Grant to Study A Novel Traumatic Brain Injury Treatment

The NIH grant will fund a project entitled “Neutrophil Extracellular Traps And Associated Pathogenesis In TBI: A Novel Peptide Therapeutic Strategy” proposed by Mohammed Abdul Muneer, MSc, PhD, Research Scientist & Principal Investigator, Hackensack Meridian Neuroscience Institute at JFK University Medical Center, and Associate Professor of Neurology at the Hackensack Meridian School of Medicine.

By using this website you agree to accept Medical Device News Magazine Privacy Policy